Clinical Trials Logo

Spastic Cerebral Palsy clinical trials

View clinical trials related to Spastic Cerebral Palsy.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06355869 Completed - Clinical trials for Spastic Cerebral Palsy

Repeatability of Gait Deviations in Children With Cerebral Palsy

Start date: August 17, 2021
Phase:
Study type: Observational

Three-dimensional gait analysis (3DGA) is the 'gold standard' for measurement and description of gait. Gait variability can arise from intrinsic and extrinsic factors and may vary between walking conditions. This study aimed to define the inter-trial (intrinsic) and inter-session (extrinsic) repeatability in gait analysis data of children with CP who were walking in four conditions, namely barefoot or with ankle-foot orthosis, and overground or treadmill.

NCT ID: NCT05719623 Completed - Clinical trials for Spastic Cerebral Palsy

Cuevas Medek Exercises on Balance and Postural Control in Children With Spastic Cerebral Palsy

Start date: February 9, 2023
Phase: N/A
Study type: Interventional

Cerebral palsy (CP) is a disorder characterized by abnormal tone, posture and movement and clinically classified based on the predominant motor syndrome-spastic hemiplegia, spastic diplegia, spastic quadriplegia, and extra-pyramidal or dyskinetic. Clinical prediction models and neuroimaging have been used to diagnose CP before the age of 2 years, but further research is necessary. Cuevas Medek Exercises (CME) is a pediatric physiotherapy approach for children with developmental motor delay impacting the central nervous system. According to Ramon Cuevas, who developed the therapy, CME are mainly based on the principle of provoking novel automatic motor reactions using exercises against gravity with progressive distal holding. This study will find the effects of Cuevas Medak Exercises on Balance and Postural control in children with spastic cerebral palsy. This Randomized Controlled Trial will recruit the participants through random sampling. Participants will be randomly divided into 2 groups. Two groups of children aged between 2 and 5 years, suffering from cerebral palsy in spastic form, one for control and one for experiment. Controlled will get conventional treatment while study group will get conventional treatment with Cuevas Medak Exercises. Treatment duration is of 12 weeks. Progress will monitored every month. The frequency of recovery sessions will 3 sessions/week, and the duration of a session will 45 minutes. Patient evaluation will be made at the beginning and the end of the treatment through pediatric balance scale and static balance test. Data will be analyzed through SPSS 25.

NCT ID: NCT05418192 Completed - Clinical trials for Spastic Cerebral Palsy

Effects of Dosing and Environment on Gross Motor and Spasticity in Spastic Quadriplegic

Start date: January 3, 2022
Phase: N/A
Study type: Interventional

This study focuses on how enriched environment along with the traditional physical therapy improves the gross motor function in spastic quadriplegic cerebral palsy children. And how much dosing is required to gain that clinically significant improvement.

NCT ID: NCT05322759 Completed - Clinical trials for Spastic Cerebral Palsy

Halliwick and Aquatic Exercises in Spastic Cerebral Palsy

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The aim of this research is to find and compare the effects of halliwick exercises and aquatic exercises on gross motor function, trunk stability and hand function in spastic cerebral palsy.

NCT ID: NCT05242796 Completed - Clinical trials for Spastic Cerebral Palsy

Effects of Low Frequency Magnet Therapy on Spasticity in Patients With Cerebral Palsy

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

Background: Spasticity is a major challenge in patients with cerebral palsy (CP). It may cause unwanted complications and may affect the patient's quality of life. Currently there is no satisfactory long lasting control of spasticity. Many lines of evidence indicate that magnet therapy may be a useful intervention in the management of spasticity. Several studies showed that magnet may inhibit neuronal firing in the human nervous system; however, its effects weren't studied on spasticity. Objectives: The goal of the present study was to determine the short-and long-term effects of pulsed low frequency magnetic field therapy on spasticity in patient with CP. Methods: 48 patients with CP, who have measureable level of spasticity, were selected. The sample was divided randomly into active magnet group (received magnet therapy, 32 subjects) and placebo group (16 subjects). At the end of the 4th week the magnet group was divided into two sub-groups: 1st sub-group received magnet therapy for another 4 weeks while the other received the placebo. Measurements was taken at baseline, 4th, 8th and 12th weeks. Modified Ashworth Scale was used to measure spasticity, foot pressure platform system was used to measure the contact area and the maximum force of the feet, gross motor function measure (GMFM) was used to measure the functional level of the patients. The cerebral palsy quality of life (CP-QoL) questionnaire was used to measure the patients' various dimensions of quality of life.

NCT ID: NCT05126693 Completed - Clinical trials for Spastic Cerebral Palsy

Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

This study investigates the effect of integrated Botulinum Neurotoxin A (BoNT) treatment on morphologic muscle and tendon properties, spasticity, joint stiffness, joint range of motion, muscle strength, gait and gross motor function. The integrated BoNT treatment combines BoNT-injections with serial casting and intensive physical therapy, as previously described by Molenaers et al. The current study will include 30 children who are clinically scheduled for BoNT treatment in the medial gastrocnemius and/or the semitendinosus muscle in the intervention group and 30 children in a control group who will receive usual care within a time span of 3 months.

NCT ID: NCT05094921 Completed - Clinical trials for Spastic Cerebral Palsy

Halliwick Concept on Motor Functions in Spastic CP

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This randomized controlled trial will investigate the effect of hydrotherapy (halliwick concept) on motor functions in children with spastic cerebral palsy (CP). Minimum of 30 Spastic CP children will be recruited for this study. Children will be randomly assigned into control group who will receive conventional selected exercise treatment or study group who will receive the same conventional program in addition to underwater exercise program. Motor function will be evaluated at baseline and after 3 months of treatment. No potential harms are expected during this study.

NCT ID: NCT04858646 Completed - Clinical trials for Spastic Cerebral Palsy

Aerobic Exercises and Gross Motor Function in Spastic Cerebral Palsy

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The aim of this research is to find the effects of aerobic exercise on gross motor function in cerebral palsy patients. Quasai experimental study done at Noor Zainab Rehabilitation center, Lahore. The sample size was 34. The subjects were divided in two groups, 17 subjects with aerobic exercise 17 children with conventional treatment. Sampling technique applied was purposive non probability sampling. Only 7-12 years individuals with GMFCS level I- III were included. Tools used in the study were Gross motor function measure (GMFM-66 and 88) .Data was be analyzed through SPSS 21.

NCT ID: NCT04634136 Completed - Quality of Life Clinical Trials

Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy

HemPhar
Start date: October 15, 2020
Phase: N/A
Study type: Interventional

The proposed study is a double-blind, placebo-controlled, cross over study on 60 children aged 5 to 25 years with severe spasticity related to cerebral palsy (CP), level IV and V with full-spectrum medical cannabis product of CBD/THC ratio 10:1.

NCT ID: NCT04322825 Completed - Clinical trials for Spastic Cerebral Palsy

Mollii - Personalized Suit for Treatment of Spasticity, GFMCS 3-5

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The objective of this study was to examine the effect on spasticity and function of multifocal transcutaneous electrical stimulation incorporated in a 2-piece (Mollii) suit.